Publications by Dr Helen Lucraft - ePrints

Browsing publications by Dr Helen Lucraft.

Newcastle Authors	Title	Year
Dr Helen Lucraft	Risk of Premature Menopause After Treatment for Hodgkin's Lymphoma	2014
Dr Helen Lucraft	Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors	2013
Dr Christopher Bacon Sarah Wilkinson Dr Gavin Spickett Dr Helen Lucraft Professor Graham Jackson et al.	Epstein-Barr virus-independent diffuse large B-cell lymphoma in DNA ligase 4 deficiency	2013
Dr Helen Lucraft	Recommendations for the Use of Radiotherapy in Nodal Lymphoma	2013
Dr Helen Lucraft	The Management of Children with Lymphomas	2013
Dr Helen Lucraft	Breast Cancer Risk After Supradiaphragmatic Radiotherapy for Hodgkin's Lymphoma in England and Wales: A National Cohort Study	2012
Professor Stephen Proctor Dr Jennifer Wilkinson Gillian Watson Dr Helen Lucraft Dr Tryfonia Mainou-Fowler et al.	Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study	2012
Professor Stephen Proctor Dr Jennifer Wilkinson Dr Helen Lucraft Dr Richard McNally Dr Tryfonia Mainou-Fowler et al.	Comparative clinical responses of three chemotherapy schedules (VEPEMB, ABVD, CLVPP) in 175 Hodgkin Lymphoma patients over 60ys evaluated as part of the Shield (Hodgkin elderly) Study	2011
Professor Stephen Proctor Dr Anne Lennard Professor Graham Jackson Dr Jennifer Wilkinson Dr Michal Sieniawski et al.	The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control	2010
Dr Helen Lucraft Professor David Ellison	Impact of radiotherapy parameters on outcome for patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study	2009
Dr Michal Sieniawski Dr Jennifer Wilkinson Dr Anne Lennard Dr Helen Lucraft Dr Tryfonia Mainou-Fowler et al.	Duration of First Remission in Diffuse Large B-Cell Lymphoma (DLBCL) Define Groups of Patients with Different Overall Survival Which Cannot Be Entirely Distinguished by Clinical Features or IPI at Diagnosis: a Prospective Population Based Study of the Scotland and Newcastle Lymphoma Group.	2008
Professor Stephen Proctor Dr Jennifer Wilkinson Dr Tryfonia Mainou-Fowler Dr Michal Sieniawski Dr Katrina Wood et al.	SHIELD - Study of Hodgkin lymphoma in the elderly/lymphoma data base: Progress report	2008
Dr Michal Sieniawski Dr Tryfonia Mainou-Fowler Dr Jennifer Wilkinson Dr John Davison Professor Graham Jackson et al.	The effect of Diffuse Large B-Cell Lymphoma (DLBCL) treatment regimens on survival: a prospective cohort study [Poster]	2008
Dr Helen Lucraft	Craniospinal irradiation using a forward planned segmented field technique	2007
Dr Penelope Taylor Dr Kevin Windebank Dr Helen Lucraft Dr Katrina Wood Dr Brian Angus et al.	Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents	2007
Dr Helen Lucraft	Patterns of outcome and prognostic factors in primary bone lymphoma (osteolymphoma): A survey of 499 cases by the international extranodal lymphoma study group	2007
Dr Shyamal Wahie Dr Helen Lucraft Professor Peter Farr	Oropharyngeal mycosis fungoides	2006
Dr Helen Lucraft Professor Roderick Skinner	Secondary parotid mucoepidermoid carcinoma after TBI and chemotherapy in childhood AML	2006
Dr Penelope Taylor Dr Brian Angus Professor Graham Jackson Dr Helen Lucraft Professor Stephen Proctor et al.	The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial	2006
Professor Stephen Proctor Dr Jennifer Wilkinson Dr Helen Lucraft Dr Penelope Taylor Dr Katrina Wood et al.	[abstract] International study of Hodgkin's lymphoma in the elderly	2004
Professor David Ellison Dr Helen Lucraft Dr Richard Gilbertson	Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma	2004
Dr Helen Lucraft	Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer	2003
Dr Helen Lucraft	Primary cutaneous diffuse large B-cell lymphoma - Prognostic significance of clinicopathological subtypes	2003
Professor David Ellison Dr Helen Lucraft Dr Richard Gilbertson	Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology United Kingdom Children's Cancer Study Group PNET-3 study	2003
Professor Stephen Proctor Professor Graham Jackson Dr Anne Lennard Dr Brian Angus Dr Katrina Wood et al.	Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK)	2003
Dr Helen Lucraft Professor Timothy Cheetham	Successful radioiodine treatment in a 3 year old child with Graves' disease following antithyroid medication induced neutropenia	2003
Dr Helen Lucraft	Association of soft tissue sarcomas other than neurofibrosarcoma with neurofibromatosis	2002
Dr Helen Lucraft	Primary cutaneous follicular lymphoma - A clinicopathologic and molecular study of 16 cases in support of a distinct entity	2002
Dr Helen Lucraft Dr Richard Gilbertson	Results of the SIOP/UKCCSG PNET-3 randomised study of pre-radiotherapy chemotherapy compared with radiotherapy alone in M0/M1 medulloblastoma	2002
Dr Edmund Ong Dr Helen Lucraft	An aggressive intrasinusoidal lymphoma presenting with marked systemic disturbance but normal imaging studies	2000
Dr Ujjal Mallick George Proud Nigel Jones Dr Helen Lucraft Dr John Fenwick et al.	Lack of antigenicity of recombinant human thyrotropin after multiple injections in patients with differentiated thyroid cancer	2000
Dr Ujjal Mallick Dr John Fenwick Dr Robert James Dr Sarah Johnson Professor Pat Kendall-Taylor et al.	Northern cancer network guidelines for management of thyroid cancer	2000
Dr Ujjal Mallick Dr Helen Lucraft George Proud Dr Petros Perros Dr John Fenwick et al.	Optimizing the management of differentiated thyroid cancer.	2000
Dr Helen Lucraft	Strategies to reduce deaths from breast cancer following mantle irradiation	2000
Dr Amanda Potterton Dr Andrew Chippindale Dr John Wilsdon Dr Helen Lucraft Dr Peter Dawes et al.	MRI appearances of the axilla in treated breast cancer	1999
Dr Nicholas Wadd Dr Helen Lucraft	Novel solutions to the problems encountered in electron irradiation to the surface of the head	1999
Professor Simon Bailey Professor Roderick Skinner Dr Helen Lucraft Emeritus Professor Robert Perry Nicholas Todd et al.	Pineal tumours in the north of England 1968-93	1996
Dr Penelope Taylor Dr Helen Lucraft Professor Stephen Proctor	Bone marrow examination in newly diagnosed Hodgkin's disease: Current practice in the United Kingdom	1995
Professor Graham Jackson Dr Anne Lennard Dr Penelope Taylor Dr Peter Carey Dr Brian Angus et al.	Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission	1994
Dr Penelope Taylor Professor Graham Jackson Dr Anne Lennard Dr Helen Lucraft Professor Stephen Proctor et al.	Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue	1993
Professor Andrew Pearson Dr Jennifer Kernahan Dr Helen Lucraft Anne Thompson Emeritus Professor Alan Craft et al.	Low dose continuous infusion doxorubicin in children and young adults	1993
Dr Penelope Taylor Dr Helen Lucraft Professor Stephen Proctor	Patient education for self-referral and on-demand treatment for herpes zoster in lymphoma patients	1993
Dr Anne Lennard Professor Stephen Proctor Dr Brian Angus Dr Helen Lucraft	Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease: A prospective study on behalf of the east of Scotland and Newcastle lymphoma group (ESNLG)	1989